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The eect of patient education on morbidity in asthmatics and COPD patients has not previously been investigated
in a single study.
We randomized 78 asthmatics and 62 COPD patients after ordinary outpatient management. Intervention
consisted of educational group sessions and individual sessions administered by a trained nurse and
physiotherapist. A self-management plan was developed. The utilization of health resources and absenteeism
from work was self-reported monthly.
During the 12-month follow-up, approximately two (P=0001) and three (P=0001) times as many uneducated
asthmatics and COPD patients, respectively, visited their general practitioner (GP) compared with educated. The
mean reduction in GP consultations for the educated were 73% (P50001) and 85% (P500001) for the asthma
and COPD group, respectively, compared with uneducated. Fifty percent of uneducated asthmatics reported
absenteeism from work compared with 24% of the educated (P=006). The mean reduction in days o work for the
educated was 69% (P=003), compared with uneducated. A positive correlation was observed between St George’s
Respiratory Questionnaire total score and number of GP visits for both the asthma and COPD group (P50001).
We conclude that patient education in asthmatics and COPD patients reduced the need for GP visits and kept a
greater proportion of patients independent of their GP. Patient education among asthmatics also reduced the
number of days o work and appeared to increase the proportion of patients not reporting absenteeism from work
at all. Increasing number of GP visits was correlated with decreased health-related quality of life as measured by the
SGRQ for both the asthmatics and the COPD patients.
Key words: Asthma, obstructive lung disease, patient education, morbidity
RESPIR. MED. (2000) 94, 279–287 # 2000 HARCOURT PUBLISHERS LTDIntroduction
In recent decades there has been an increase in morbidity
and mortality due to asthma and chronic obstructive
pulmonary disease (COPD) (1,2). National and interna-
tional expert panels have produced guidelines to confront
these developing problems (2–6). All the guidelines
emphasize the importance of patient education and self-
management and discuss dierent types of treatment plans,
especially for asthmatics, but increasingly so also for COPD
patients.Received 29 June 1999 and accepted 10 November 1999.
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0954-6111/00/030279+09 $35?00/0Nevertheless, there are only 15 studies in the literature
reporting randomized controlled asthma management trials
(7) and only two studies evaluating the impact of patient
education on patients with COPD (8).
Regarding the asthma studies, only three have examined
the eect of self-management on absenteeism from work
(9–11), while two (10,11) and six (9,10,12–15) studies have
investigated the influence on the number of general
practitioner (GP) visits and days in hospital, respectively.
Reports assessing GP visits and absenteeism from work
observed a positive eect due to intervention. Conflicting
results have been presented regarding days in hospital;
some studies have reported a positive eect (10,13–15), but
not all (9,12). None of the published studies observing a
reduced utilization of health services and absenteeism from
work have examined how this reduction is distributed in the
populations surveyed. To our knowledge, there is no data
available examining to what extent education programmes# 2000 HARCOURT PUBLISHERS LTD
280 F. GALLEFOSS AND P. S. BAKKEinfluence GP-consultation rates and absenteeism from work
in COPD patients (8,16).
We performed a randomized, controlled intervention
study in patients with mild to moderate asthma or COPD
using a standardized education programme and a self-
management plan. The objectives of the present report were
to assess the eect of this intervention on GP visits and
absenteeism from work. We also registered the number of
hospitalizations due to obstructive episodes. Furthermore,
we assessed the relationship between health-related quality
of life and number of GP-visits during the 1-year follow-up.
Subjects and methods
STUDY DESIGN
Permission to establish a person register was given from the
National Data Supervision Centre. The methodological
procedures were in accordance with the ethical standards of
the Helsinki Declaration as approved by the regional
ethical committee.
Between May 1st, 1994 and December 1st, 1995, 140
consecutive patients with symptomatic obstructive lung
disease were included in the study after having received
ordinary consultation care at our outpatient chest clinic at
the Central Hospital of Vest-Agder, Kristiansand, Norway.
At inclusion they signed a written consent and were then
randomized to an intervention group or a control group
using random number tables.
The control group was followed by their GPs, while the
intervention group first received an education programme
and were then also transferred to a 1-year follow-up by
their GPs (Fig. 1). The availability and organization of GP
care was similar in the two treatment groups.
Eligible subjects were patients with bronchial asthma or
COPD between 18 and 70 years of age, not suering fromFIG. 1. Study design and withdrawals.any other serious disease, such as unstable coronary heart
disease, heart failure, serious hypertension, diabetes melli-
tus, kidney or liver failure.
The primary inclusion criteria for asthmatics was a
prebronchodilator FEV1 equal to or higher than 80% of
predicted value (17). Furthermore, we required either a
positive reversibility test (17), a documented 20% sponta-
neous variability [peak expiratory flow (PEF) or FEV1] or a
positive metacholine test (PD20) (18). A positive reversi-
bility test was defined as 20% increase (FEV1 or PEF)
after inhalation of 400 mg salbutamol. Subjects with COPD
were included with an FEV140% and 80% of predicted.
Among patients with COPD, 32% were reversible to
ipratropium bromide 80 mg and/or salbutamol (2,19).
These measures were obtained from the participants’
charts. Prebronchodilator spirometry was performed prior
to randomization by standard methods (17) using a Jaeger
MasterLab Body Box (Wu¨rzburg, Germany).
Of the eligible patients, the inclusion rate was 92% (78 of
85) and 91% (62 of 68) for the asthma and COPD group,
respectively.
EDUCATIONAL INTERVENTION
None of the randomized patients had earlier received
organized education regarding obstructive lung disease.
The educational intervention has been thoroughly de-
scribed recently (20). Briefly, it consisted of a specially
constructed patient brochure, two 2-h group sessions
(separate groups for asthmatics and patients with COPD).
One or two 40-min individual sessions were supplied by
both a nurse and a physiotherapist (Fig. 1). In these
sessions, the components of obstruction were explained
together with the site of action of the actual medication.
The patient’s symptoms were registered and discussed with
emphasis on the early symptoms of exacerbation. Fears of
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technique was checked. The importance of smoking
cessation was emphasized. In the final session, patients
received an individual treatment plan on the basis of the
acquired personal information and 2 weeks of peak flow
monitoring (20). The personal understanding of the
treatment plan with regard to changes in PEF and
symptoms was discussed and tested (Table 1).
All patients received step-wise treatment plans aimed at
making early changes in medication at exacerbations.
Among the educated asthmatics 94% (32 of 34) received
standard step-wise treatment plans (Table 1) incorporating
the monitoring of peak expiratory flow (PEF). In the
COPD group 45% (12 of 26) received this standard
treatment plan. Non-standard treatment plans, incorporat-
ing the use of oral steroids as the first line of action in the
yellow zone, were followed, if, for example, the patient
already used high dosages of inhaled steroids as main-
tenance therapy or could report that a double or triple
increase in inhaled steroids previously had shown marginal
eect on the course of attacks/exacerbations. Among 14
patients with COPD receiving non-standard treatment
plans, eight patients did not want to or were not able to
use peak flow monitoring as a basis for change in
medication. For those patients, symptom-only based
treatment plans were issued (Table 1).
OUTCOME VARIABLES
The number of GP-visits, absenteeism from work and days
in hospital was self-reported at monthly intervals. Wording
of the questions and the pre-printed alternatives for
answering were:
Since the last time you reported, have you (due to asthma/
COPD):
1. consulted a doctor? Yes & No &
If so, did you consult a doctor due to increased
diculty with breathing? Yes & No &TABLE 1. Model for the step-wise treatment plan
Colour code PEF* Symptoms
Green 480% No symptoms, occasional use of i
b2-agonist
Yellow 80–60% Start of a cold, night symptoms, c
or increased use of inhaled b2-ago
Orange 60–40% or
4150 l/min71
The eect of inhaled b2-agonists l
52 h, shortness of breath on exer
Red 540% or
5150 l/min71
Inhaled b2-agonists of little help o
eect lasts530 min, shortness of
breath when talking
*in relation to personal best2. been o work? Yes & No &
3. been hospitalized? Yes & No &
In addition, specific dates and doctor identities were
requested. Hospital data were checked against hospital
records. Each patient was supplied with 12 self-addressed,
stamped envelopes and 12 standardized registration forms
to be mailed the first day of each month. Dunning letters
were sent within 2 weeks when needed. At the 12-month
follow-up, all the registration forms were checked during
the interview with the patient to ensure the accuracy of the
registrations.
At the 1-year follow-up, patients completed the St.
George’s Respiratory Questionnaire (SGRQ) (21). The
SGRQ is a disease-specific quality of life instrument and
has 76 items which are weighted to produce three
component scores: ‘Symptoms’, measuring distress due to
respiratory symptoms; ‘Activity’, measuring the eect of
disturbances to mobility and physical activity; and ‘Im-
pacts’, quantifying the psychosocial impact of the disease.
A number of items in the Symptoms component relate to
the frequency of symptoms over the previous year. Both the
Activity and Impacts components relate to the patient’s
current state. A ‘Total’ score is also calculated from all
component items, thus providing a global estimation of the
patients’ respiratory health. Each of these scores ranges
from 0 to 100, a score of 100 indicating maximum disability
(22). A dierence of four units indicates a slight clinical
eect, a dierence of eight or 12 units indicates moderate or
very good clinical eects, respectively (23).
STATISTICS
A number of the outcome variables showed a skewed
frequency distribution. In these cases, the median (the value
that separated the highest 50% of the scores from the
lowest 50%) values are shown as a measure of central
tendency with the 25th and 75th percentiles (the inter-
quartile range) as a measure of dispersion. For normally




Double or triple dosage of inhalation steroids until
back in green zone, then continue double or triple
dosage for as long time as outside green zone
asts
tion
Prednisolone 30–40 mg/ day until back in green
zone, then 10–20 mg/day for as long time you were
outside green zone
r Take Prednisolone 40 mg and high dose inhaled b2-
agonist and contact doctor immediately
TABLE 2. Baseline characteristics of study participants
Asthma COPD
Control group Intervention group Control group Intervention group
(n=39) (n=39) (n=31) (n=31)
Sex, men, n (%) 8 (21) 15 (39) 16 (52) 15 (48)
Age, mean (SD), years 44 (12) 41 (12) 58 (10) 57 (9)
Smoking habits
current smokers, n (%)
13 (33) 9 (23) 12 (39) 12 (39)
packyears, median* 11 6 17 17
Duration of symptoms, median, years*, ** 6 7 13 15
Employed, n (%) 24 (62) 29 (74) 16 (52) 14 (45)
FEV1 % predicted, mean (SD) 95 (17) 93 (13) 56 (11) 59 (9)
FVC % predicted, mean (SD) 105 (15) 104 (12) 89 (12) 88 (14)
Current use of peak flow meter, n (%) 12 (31) 16 (41) 4 (13) 9 (29)
*Median values are employed for non-normally distributed data.
**Based on the question: how long have you had asthma/COPD symptoms?
FIG 2. Proportion of patients making one or more GP
visits during the 12-month follow-up.
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applied when comparing continuous, skewed variables
between groups. Chi square-test is applied for categorized
dependent variables, also giving the odds ratio. Significant
associations are in addition tested with other explanatory
variables in multiple logistic regression models. All tests are
two-sided. An a5005 is considered statistically significant.
Bivariate non-parametric (rank) correlation analysis
[Spearman’s correlation coecient rho (r)] is employed
testing the correlation between St. George’s Respiratory
Questionnaire scores (SGRQ) and GP visits. Multiple
linear regression analysis is applied when determinants for
the SGRQ scores are investigated. The models are
condensed by selecting the best combination of explanatory
variables to predict the response variable by excluding those
variables that had standardized regression coecients close
to zero and high P-values.
Percentage ‘acute GP visits’ is calculated as: (number of
GP visits due to worsening of dyspnea/number of GP
visits)6100
Although skewed data imply the display of median (25th
and 75th percentiles) values, mean (SD) values are also
shown in Table 2 for better interpretation of data.
All data were initially registered in Data-Ease version
4.24. All analyses were performed on Compaq computers
using the SPSS version 7.5 (Statistical Package for the
Social Sciences, SPSS Inc., Chicago, U.S.A.).
Results
The study population consisted of 140 patients, with 39
patients randomized to each asthma treatment group and
31 to each COPD treatment group (Table 2). Baseline
patient characteristics are shown in Table 2.
In the intervention group, nine patients failed to
complete the intervention programme, and another threepatients withdrew from the study during the follow-up
period (Fig. 1). In the control group, four patients were not
reached at follow-up. Two of the withdrawn control
patients were hospitalized for COPD exacerbations, while
none of the withdrawn intervention patients were. This left
us with 58 intervention patients and 66 control patients at
the 1 year follow-up (Fig. 1). Details about withdrawals are
previously described (20).
During the 12-month follow-up, approximately two and
three times as many control patients as intervention
patients visited their GPs in the asthma and COPD group,
respectively (Fig. 2). The odds ratio for seeing their GP
during the 12-month period given an asthma control
patient compared with an asthma intervention patient,
was 51 [95% confidence interval (CI) 18–142]. The
corresponding figures for the COPD group were 15.6
[95% CI: 4.0–61]. These odds ratios did not vary overtly
after adjusting for sex, age and smoking habits in a logistic
regression analysis.
In the educated asthma group, GP visits were reduced by
73% compared with the control group. The 25% most
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GP on one or more occasion during the 12-month follow-
up compared with four or more occasions in the control
group. For the educated COPD group, we found a mean
reduction in GP visits of 85% while the 25% most frequent
GP consulters showed the same figures as for the asthma
group. The statistically significant dierences in GP visits
between the intervention and control groups were also
maintained when the first and last six month periods were
investigated separately (all Ps5002, Mann–WhitneyU-test).
Among those consulting their GPs, the median (25th/
75th percentiles) consultation rates were 25 (1/5) and 1(1/2)
in the asthma control and intervention group, respectively
(P=012, Mann–Whitney U-test), while the corresponding
median values for the COPD group were 2 (1/5) and 1 (1/2)
(P=029). The maximum numbers of consultations in the
asthma and COPD groups were 16 vs. 11 and 27 vs. 4 in the
control and intervention groups, respectively.
Of all GP visits during the 12-month follow-up, the
percentages of ‘acute GP visits’ due to asthma problems
were 59 and 67% (n.s., Mann–Whitney U-test) in the
control and intervention group, respectively. The corre-
sponding values for the COPD group were 64 and 67%
(n.s.).
Regarding occupational status, at the 1-year follow-up,
62% had a regular job in the asthma control group
compared with 78% in the intervention group. The
corresponding values for the COPD groups were 52 and
50%. In the asthma control group, 50% (12 of 24) of the
employed patients reported absenteeism from work due to
pulmonary symptoms during the 12 month follow-up,
compared with 24% (6 of 25) in the educated group
(P=006, chi-square test) (Table 3). The corresponding
values for the COPD group were 21% (3 of 14) and 15% (2
of 13), respectively, but the figures are not interpretable due
to small numbers (P=069).
In the educated asthma group, there was a mean
reduction in absenteeism from work of 69% compared
with the control group. The 25% most frequently reporting
ill in the educated group were absent from work  03 days
during the 12-month follow-up, compared with  20 days
in the control group. For the educated COPD group, we
observed a mean 95% reduction in absenteeism from work
compared with control.
When excluding the unemployed, we observed a strong
correlation in the asthma group between number of GP
visits and absenteeism from work (Spearman’s correlation
coecient =071, P50001) (Fig. 3). The corresponding
values for the COPD group was 042, P=0028.
Days in hospital due to asthma and COPD exacerbations
are shown in Table 3. These numbers are not conclusive due
to few events. In the asthma group there was no admittance
to hospital in the control group, while two individuals in the
educated group were admitted on one occasion each for 4
and 5 days, respectively. For the COPD control group, four
individuals were admitted for 5 days (median), while three
individuals stayed 6 days (median) in the intervention group.
Figure 4 shows that the number of GP visits was
positively correlated with SGRQ total score at the 1-year
follow-up, the correlation being strongest for the asthmagroup. For the asthma group, bivariate non-parametric
regression analysis showed moderate correlations between
GP visits and SGRQ scores given as 050 (Spearman’s rho,
P50001). The corresponding value for the COPD group
was 038, P=0005.
To investigate this relationship further, the determinants
for the normally distributed SGRQ scores (i.e. GP visits,
absenteeism from work, age, sex, treatment group and
smoke status), were analysed in a multiple linear regression
analysis. GP visits was the only explanatory variable that
appeared in all the condensed models, uncovering the
general trend that SGRQ total scores were correlated with
GP visits in both the asthma and COPD group. The
unstandardized regression coecient for the total scores
was 20 (r=065, 95% CI 08–33, P=0003) in the asthma
group and 32, (r=060, 95% CI 1.7–4.6, P=0001) in the
COPD group.
Discussion
This study demonstrated that patient education and self-
management among asthmatics and COPD patients re-
duced the need for GP visits and kept a greater proportion
of patients independent of their GP during a 12-month
follow-up, when compared with traditional treatment at
our outpatient clinic. Patient education among asthmatics
also reduced the number of days o work, and seemed to
increase the proportion of patients not reporting absentee-
ism from work at all. Increasing number of GP visits was
associated with decreased health-related quality of life as
measured by the SGRQ for both asthmatics and patients
with COPD.
The information on GP visits, absenteeism from work
and days in hospital was self-reported every month.
Frequent reporting tends to reduce recall bias, compared
with a single assessment at follow-up. On the other hand it
may influence the results by reminding the patients of the
study. However, this potential Hawthorne eect should
work equally in both intervention and control groups,
therefore not influencing the intervention group specifically.
One could argue that this information could have been
obtained from other sources. Information directly from the
GP about patient visits might have had the advantage of
yielding more accurate information. But such an active
involvement of GPs could have produced a bias in the
study, by altering natural patterns of patient care.
Absenteeism from work was also self-reported. This
information could have been acquired from the various
local Social Security Oces. However, in Norway, the
Social Security database is not able to provide information
on sick leave of 3 days or less, so this information source
would have resulted in missing data on short sick leave.
Our finding that patient education reduced GP visits in
asthmatics agrees with previous surveys (10,11). However,
interpretation of the study by Ignacio-Garcia and collea-
gues (10) is hampered by high withdrawal rates of those not
complying with peak flow monitoring or treatment regi-
mens, thus showing an eect of education on highly
selected subjects (24). In the present study, high inclusion
TABLE 3. GP consultations, absenteeism from work and days in hospital due to asthma and COPD during a 12 month follow-up
Asthma COPD
Control Intervention Control Intervention
(n=39) (n=32) (n=27) (n=26)
Median* Mean (SD) Median* Mean (SD) P Median* Mean (SD) Median* Mean (SD) P
GP consultations 1 (0/4) 26 (36) 0 (0/1) 07 (2) 50001 1 (1/4) 34 (55) 0 (0/1) 05 (0,9) 500001
Absenteeism from work** 1 (0/20) 26 (70) 0 (0/03) 8 (32) 003 0 (0/03) 185 (86) 0 (0/0) 1 (7) 064
Days in hospital 0 (0/0) 0 0 (0/0) 03 (1) 012 0 (0/0) 25 (11) 0 (0/0) 07 (2) 074
*Median values (25th and 75th percentiles).
























FIG 3. Association between absenteeism from work and
GP visits (categorized into three groups) during the 12-
month follow-up.
FIG 4. Association between St George’s Respiratory
Questionnaire total scores at the 12-month follow-up and
GP visits (categorized into three groups) during the 12-
month follow-up.
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applicable to the asthma community. To our knowledge,
this is the first study to show that patient education and
self-management in COPD patients reduce the need for GP
visits.
The 75th percentile values for the asthmatics and COPD
patients indicate that patient education was also eective in
reducing GP visits for the frequent users. This view is also
supported by the lower standard deviations and maximum
number of GP visits in the educated groups, compared with
the uneducated. The fact that the dierences in GP visits
between the intervention and control groups remained
statistically significant throughout the 12-month follow-up
suggests a higher degree of sustained self-management. The
wording of the question on GP visits due to worsening of
dyspnoea prevents us from distinguishing between short-
term scheduled (due to exacerbations) and unscheduled
(acute) visits. However, the ticking o for ‘yes’ on
worsening of dyspnoea should exclude long-term scheduled
visits. We have no data on whether the low number of GP
visits in the educational groups were due to non-compliance
to scheduled visits, but have not received any information
that such behaviour became more common in the
intervention groups. Rather, we believe that the reducednumber of GP visits were linked to good asthma and
COPD control, supported by the observed correlation
between SGRQ scores and GP visits.
The percentage of patients that seemed totally indepen-
dent of their GP during 1-year follow-up as judged by no
visit to their GP at all, also increased significantly by two
and three times in the educated asthma and COPD groups,
respectively, compared with the uneducated. To our
knowledge, we are the first to report this finding after
patient education both for asthmatics and COPD patients.
The clinical implication of this seems important as the
uneducated asthmatic and COPD patients were about 2.5
and three times as likely to consult their GP, respectively,
compared with the educated.
We found a reduction in absenteeism from work in the
educated asthma group compared with the control group.
This is in agreement with previous randomized controlled
studies (10,11). The present study extends this knowledge
by observing that the percentage of asthma patients not
reporting absenteeism from work at all was doubled in the
control group compared with the educated group. This
result implies that an uneducated asthmatic is two times as
likely to report absenteeism from work during a 12-month
follow-up, compared with an educated.
With regard to hospitalizations due to asthma and
COPD problems, it should be emphasized that one of the
inclusion criteria for our study was that the patient should
be followed by their GP without any arranged follow-up
appointment at the pulmonary outpatient clinic. This
implies that we did not include those who frequently
utilized specialist services. As can be seen from the data,
hospital admissions were rare in both the asthma and
COPD groups and conclusions can not be made. Three
previous randomized controlled asthma management stu-
dies investigating asthma patients that had been hospita-
lized or admitted to emergency rooms for their asthma
problems (13,15,24), found a reduction in hospital admis-
sions in the educated group compared with the control
group. In their large trial (n=801), Osman and colleagues
(14) observed that hospital admissions were reduced due to
asthma education, although the patients were recruited
from the outpatient clinic.
We found a moderate to strong correlation between all
the 12-month follow-up SGRQ scores and numbers of GP
visits. In the asthma group, one GP visit during the last year
was associated with about a two-unit higher SGRQ total
score. The corresponding value in the COPD group was
approximately three units. Since a dierence of four and
eight units in SGRQ total score indicates a slight and
moderate clinical eect, respectively (23), two or three GP
visits during a 12-month follow-up was correlated with a
clinically significant reduction in health related quality of
life. To our knowledge, this correlation has not been
previously reported.
Osman has previously reported an association between
pre-study SGRQ scores and re-admissions for COPD
patients (25).
From the same study, we have previously reported the
eect of patient education on compliance and rescue
medication utilization (26). The baseline medication was
286 F. GALLEFOSS AND P. S. BAKKEcomparable in the various treatment groups. We found
improved steroid inhaler compliance in the educated
asthma group compared with the uneducated, but it was
not correlated with GP visits or number of days o work.
There could be several explanations to why our inter-
vention appeared eective with regard to the variables
measured. Firstly, our patient approach might have been
valuable, since we tried to uncover the patients’ fears and
concerns about their disease and treatment, allowing the
patients to overcome psychological barriers resulting in
more rational behaviour (27). Second, we tried not to
overload our patients with information, instead distilling
our study guidelines and treatment plans down to very
simple concepts. Third, at exacerbations we emphasized the
early change of medication in the treatment plans. This may
have resulted in less need for doctor assistance. Fourth, the
educated patients may have been made more aware of the
clinical implications of their symptoms than the unedu-
cated, thereby avoiding unnecessary consultations due to
doubt and anxiety. Fifth, all educated patients received a
specially made 19-page information booklet which during
the follow-up year could be an important source of
information and reinforcement. Finally, the treatment plan
incorporated where possible, both the supervision of
symptoms and signs and the monitoring of peak flow.
Most guidelines now suggest self-management plans based
both on both symptoms and peak flow monitoring (3, 4,
28–32). Nevertheless, we are not able to tell which
component of our intervention was most eective or to
argue which component was ineective. Such research is
warranted (33).
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